SCHEMBL7984722

SCHEMBL7984722

OCc1ccoc1Cn1c(NC2CCNCC2)nc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.60
NR4A2 P43354 2/20 0.60
SSTR5 P35346 7/20 0.44
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
SOS1 Q07889 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MLNR O43193 1/20 0.38
CACNA1F O60840 1/20 0.38
EED O75530 1/20 0.38
USP2 O75604 1/20 0.38
ABCB11 O95342 1/20 0.38
EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9876847 0.84 KCNH2 (0.61) KCNH2NR4A2SSTR5LMNAGAA
SCHEMBL6996422 0.81 KCNH2 (0.62) KCNH2NR4A2SSTR5LMNAGAA
SCHEMBL7500613 0.81 KCNH2 (0.65) KCNH2NR4A2SSTR5LMNAALDH1A1
SCHEMBL7970819 0.81 KDM4E (0.51) SSTR5LMNAGAAALDH1A1MEN1
SCHEMBL11265895 0.79 KCNH2 (0.83) KCNH2NR4A2SSTR5LMNAGAA
SCHEMBL7985049 0.79 KCNH2 (0.65) KCNH2NR4A2SSTR5MKNK1IRAK4
SCHEMBL5110805 0.79 KCNH2 (0.65) KCNH2NR4A2SSTR5LMNAGAA
Bromide SCHEMBL11305424 0.78 KCNH2 (0.81) KCNH2NR4A2SSTR5LMNAGAA
SCHEMBL7988153 0.78 KCNH2 (0.70) KCNH2NR4A2SSTR5LMNAGAA
Hydrochloric Acid SCHEMBL9302235 0.77 KCNH2 (0.57) KCNH2NR4A2SSTR5LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed